• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UGT1A1基因变异与儿童非酒精性脂肪性肝病风险

Variants in the UGT1A1 gene and the risk of pediatric nonalcoholic fatty liver disease.

作者信息

Lin Yu-Cheng, Chang Pi-Feng, Hu Fu-Chang, Chang Mei-Hwei, Ni Yen-Hsuan

机构信息

Department of Pediatrics, Far Eastern Memorial Hospital, Taipei, Taiwan.

出版信息

Pediatrics. 2009 Dec;124(6):e1221-7. doi: 10.1542/peds.2008-3087.

DOI:10.1542/peds.2008-3087
PMID:19948621
Abstract

OBJECTIVE

Oxidative stress is increased in nonalcoholic fatty liver disease (NAFLD). Variants in the UGT1A1 gene contribute to increased bilirubin levels, and bilirubin can act as an antioxidant. We hypothesize that variant UGT1A1 genotypes reduce the risk for NAFLD development.

METHODS

Two hundred thirty-four obese children 6 to 13 years of age were recruited. NAFLD was determined through liver ultrasonography. The UGT1A1 genotypes UGT1A16 and UGT1A128 were detected. We assessed the effects of UGT1A1 genotypes on pediatric NAFLD.

RESULTS

In total, 12% of the obese children had NAFLD. The subjects with NAFLD had lower serum total bilirubin levels (0.25 +/- 0.30 mg/dL) than did those without NAFLD (0.36 +/- 0.38 mg/dL; P = .021). With conditioning on the effects of age- and gender-adjusted BMI, waist/hip ratio, and adiponectin levels, variant UGT1A16 genotypes were a protecting factor for NAFLD, with an estimated adjusted odds ratio of 0.31 (95% confidence interval: 0.11-0.91; P = .033), but variant UGT1A128 genotypes were not significantly associated with the occurrence of NAFLD.

CONCLUSIONS

Variant UGT1A1*6 genotypes are associated with a lower risk of NAFLD in obese Taiwanese children. The UGT1A1 genotype is a new risk factor for pediatric NAFLD.

摘要

目的

非酒精性脂肪性肝病(NAFLD)中氧化应激增加。UGT1A1基因的变异会导致胆红素水平升高,而胆红素可作为一种抗氧化剂。我们推测UGT1A1基因变异型基因型可降低NAFLD发生风险。

方法

招募了234名6至13岁的肥胖儿童。通过肝脏超声检查确定是否患有NAFLD。检测UGT1A1基因型UGT1A16和UGT1A128。我们评估了UGT1A1基因型对儿童NAFLD的影响。

结果

总共有12%的肥胖儿童患有NAFLD。患有NAFLD的受试者血清总胆红素水平(0.25±0.30mg/dL)低于未患NAFLD的受试者(0.36±0.38mg/dL;P = 0.021)。在对年龄、性别调整后的体重指数、腰臀比和脂联素水平的影响进行校正后,UGT1A16基因变异型基因型是NAFLD的一个保护因素,估计校正比值比为0.31(95%置信区间:0.11 - 0.91;P = 0.033),但UGT1A128基因变异型基因型与NAFLD的发生无显著相关性。

结论

UGT1A1*6基因变异型基因型与台湾肥胖儿童患NAFLD的风险较低相关。UGT1A1基因型是儿童NAFLD的一个新的风险因素。

相似文献

1
Variants in the UGT1A1 gene and the risk of pediatric nonalcoholic fatty liver disease.UGT1A1基因变异与儿童非酒精性脂肪性肝病风险
Pediatrics. 2009 Dec;124(6):e1221-7. doi: 10.1542/peds.2008-3087.
2
A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children.载脂蛋白基因中的一个常见变异是台湾肥胖儿童非酒精性脂肪肝的一个危险因素。
J Pediatr. 2011 May;158(5):740-4. doi: 10.1016/j.jpeds.2010.11.016. Epub 2010 Dec 18.
3
Antioxidant effect of bilirubin and pediatric nonalcoholic fatty liver disease.胆红素的抗氧化作用与小儿非酒精性脂肪性肝病
Pediatrics. 2009 Dec;124(6):e1240-1. doi: 10.1542/peds.2009-2487.
4
Body fat percentage is a major determinant of total bilirubin independently of UGT1A1*28 polymorphism in young obese.在年轻肥胖人群中,体脂百分比是总胆红素的主要决定因素,与UGT1A1*28基因多态性无关。
PLoS One. 2014 Jun 5;9(6):e98467. doi: 10.1371/journal.pone.0098467. eCollection 2014.
5
A Val227Ala substitution in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene associated with non-alcoholic fatty liver disease and decreased waist circumference and waist-to-hip ratio.过氧化物酶体增殖物激活受体α(PPARα)基因中的Val227Ala替换与非酒精性脂肪性肝病相关,并与腰围和腰臀比降低有关。
J Gastroenterol Hepatol. 2008 Sep;23(9):1415-8. doi: 10.1111/j.1440-1746.2008.05523.x.
6
A functional polymorphism in UGT1A1 related to hyperbilirubinemia is associated with a decreased risk for Crohn's disease.UGT1A1 基因的一个与高胆红素血症相关的功能性多态性与克罗恩病风险降低有关。
J Crohns Colitis. 2012 Jun;6(5):597-602. doi: 10.1016/j.crohns.2011.11.010. Epub 2011 Dec 16.
7
Association of serum bilirubin and promoter variations in HMOX1 and UGT1A1 genes with sporadic colorectal cancer.血清胆红素与 HMOX1 和 UGT1A1 基因启动子变异在散发性结直肠癌中的相关性。
Int J Cancer. 2012 Oct 1;131(7):1549-55. doi: 10.1002/ijc.27412. Epub 2012 Feb 18.
8
Heme oxygenase-1 gene promoter polymorphism and the risk of pediatric nonalcoholic fatty liver disease.血红素加氧酶-1基因启动子多态性与小儿非酒精性脂肪性肝病的风险
Int J Obes (Lond). 2015 Aug;39(8):1236-40. doi: 10.1038/ijo.2015.46. Epub 2015 Apr 3.
9
Genetically Regulated Bilirubin and Risk of Non-alcoholic Fatty Liver Disease: A Mendelian Randomization Study.基因调控胆红素与非酒精性脂肪性肝病风险:一项孟德尔随机化研究
Front Genet. 2018 Dec 18;9:662. doi: 10.3389/fgene.2018.00662. eCollection 2018.
10
Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels.非酒精性脂肪性肝病患者血清抵抗素水平升高,脂联素水平降低。
Eur J Gastroenterol Hepatol. 2009 Jun;21(6):662-6. doi: 10.1097/MEG.0b013e328317f4b5.

引用本文的文献

1
The Evaluation of the Genetic Variation Types of the Gene by Next-Generation Sequencing and Their Effects on Bilirubin Levels in Obese Children.应用下一代测序技术评估基因的遗传变异类型及其对肥胖儿童胆红素水平的影响。
Genet Test Mol Biomarkers. 2024 Jul;28(7):275-280. doi: 10.1089/gtmb.2023.0365. Epub 2024 Jun 25.
2
Significant roles of potential genes and their mutations in nonalcoholic fatty liver disease.潜在基因及其突变在非酒精性脂肪性肝病中的重要作用。
Clin Exp Hepatol. 2023 Jun;9(2):95-105. doi: 10.5114/ceh.2023.128633. Epub 2023 Jun 21.
3
Assessing the causal relationships between human blood metabolites and the risk of NAFLD: A comprehensive mendelian randomization study.
评估人体血液代谢物与非酒精性脂肪性肝病风险之间的因果关系:一项全面的孟德尔随机化研究。
Front Genet. 2023 Mar 28;14:1108086. doi: 10.3389/fgene.2023.1108086. eCollection 2023.
4
Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways.代谢相关性脂肪性肝病(MAFLD)的分子机制:脂质代谢途径的功能分析。
Clin Sci (Lond). 2022 Sep 30;136(18):1347-1366. doi: 10.1042/CS20220572.
5
Reactive Oxygen Species (ROS) and Antioxidants as Immunomodulators in Exercise: Implications for Heme Oxygenase and Bilirubin.活性氧(ROS)与抗氧化剂作为运动中的免疫调节剂:对血红素加氧酶和胆红素的影响
Antioxidants (Basel). 2022 Jan 18;11(2):179. doi: 10.3390/antiox11020179.
6
Relationship of circulating total bilirubin, UDP-glucuronosyltransferases 1A1 and the development of non-alcoholic fatty liver disease: a cross-sectional study.循环总胆红素、尿苷二磷酸葡萄糖醛酸转移酶 1A1 与非酒精性脂肪性肝病发展的关系:一项横断面研究。
BMC Gastroenterol. 2022 Jan 5;22(1):6. doi: 10.1186/s12876-021-02088-7.
7
Association of Serum Bilirubin and Functional Variants of Heme Oxygenase 1 and Bilirubin UDP-Glucuronosyl Transferase Genes in Czech Adult Patients with Non-Alcoholic Fatty Liver Disease.捷克非酒精性脂肪性肝病成年患者血清胆红素与血红素加氧酶1及胆红素UDP-葡萄糖醛酸基转移酶基因功能变体的关联
Antioxidants (Basel). 2021 Dec 15;10(12):2000. doi: 10.3390/antiox10122000.
8
Association of Serum Bilirubin Level with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study of 1672 Obese Children.血清胆红素水平与代谢综合征及非酒精性脂肪性肝病的关联:一项对1672名肥胖儿童的横断面研究
J Clin Med. 2021 Jun 25;10(13):2812. doi: 10.3390/jcm10132812.
9
New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver Disease.儿童代谢相关脂肪性肝病基因预测的新视角
Front Pediatr. 2020 Dec 9;8:603654. doi: 10.3389/fped.2020.603654. eCollection 2020.
10
Bilirubin as a metabolic hormone: the physiological relevance of low levels.胆红素作为一种代谢激素:低水平的生理相关性。
Am J Physiol Endocrinol Metab. 2021 Feb 1;320(2):E191-E207. doi: 10.1152/ajpendo.00405.2020. Epub 2020 Dec 7.